NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery

Radiation-induced hearing loss is a major quality-of-life burden for vestibular schwannoma patients, and identifying a targetable enzyme pathway could eventually lead to a pharmacological hearing-protection strategy during radiosurgery.